期刊文献+

卵巢上皮肿瘤组织Fas、Angs、E-cad的表达水平及意义分析 被引量:3

Expression of Fas, Angs, E-cad and the Significance Analysis in Ovarian Epithelial Tumor Tissues
原文传递
导出
摘要 目的检测Fas、促血管生成素-1(Ang-1)、促血管生成素-2(Ang-2)、E-钙粘蛋白(E-cad)在卵巢上皮肿瘤组织中的表达水平,藉此评价其与肿瘤发生发展及预后的关系。方法应用免疫组织化学S-P法和原位杂交技术,检查了21例卵巢上皮恶性肿瘤,18例良性肿瘤,8例正常卵巢组织中Fas,Ang-1,Ang-2及E-cad的表达。结果 Fas的表达随肿瘤病变程度的增高而逐步减弱,恶性肿瘤组织与正常卵巢及良性肿瘤组织间有显著差异(P<0.05);E-cad免疫反应阳性强度在卵巢上皮癌组织中明显降低,与正常卵巢及良性肿瘤组织间有显著性差异(P<0.05)。原位杂交显示,Ang-1 mRNA在正常卵巢及肿瘤组织中都有表达,其表达水平没有显著差异(P>0.05);Ang-2 mRNA在恶性肿瘤组织中表达明显上调(P<0.01);E-cad mRNA在恶性肿瘤组织中表达明显下调(P<0.01)。结论 Fas的表达水平与卵巢上皮肿瘤的内在发展相关;由E-cad介导的细胞间黏附作用的减弱是卵巢癌发生、发展及转移的一个重要因素;Ang-2对于促进卵巢癌组织血管新生和形成可能具有重要促进作用。 Objective To examine the expression level of Fas, Ang-1, Ang-2, E-cad in human ovarian epithelial tumors and explore their relationship with tumorigenesis and prognosis. Methods Immunohistochemical S-P staining and in situ hybridization were used to determine the expression level of Fas, Ang-1, Ang-2, E-cad in benign, malignant tumors and normal ovarian tissues. Results ( 1 ) Immunohistochemical staining revealed that Fas expression decreased with malignancy degree of tumors and E-cad was weakly expressed in malignant tumor tissues as compared with benign tumors and normal ovarian tissues ( P 〈 0. 05 ) ; (2) In situ hybridization showed that Ang-1 mRNA expressed in both ovarian tumors and normal tissues and the difference in the expression level between them was not significant ( P 〉 0.05 ). The expression of Ang-2 mRNA wasmore marked in malignant tumors than that in normal tissues and benign tumors (P 〈 0. 01 ). The expression of E-cad mRNA was obviously down-regulated in malignant tumors ( P 〈 0.01 ). Conclusion The expression level of Fas is correlated with internal development of ovarian epithelial tumors. The alteration of the intercellular adherence mediated by E-cad is an important factor in tumorigenesis and metastasis. Ang-2 may play an important role in promoting tumor angiogenesis in ovarian epithelial neoplasms.
出处 《医学分子生物学杂志》 CAS CSCD 2005年第6期413-417,共5页 Journal of Medical Molecular Biology
基金 湖北省卫生厅重点项目(No.JXIB002)
关键词 卵巢上皮肿瘤 FAS 促血管生成素-1 促血管生成素-2 E-钙粘蛋白 ovarian epithelial neoplasm Fas Ang-1 Ang-2 E-cadherin
  • 相关文献

参考文献13

  • 1Lauren J, Gunji Y, Alitalo K. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am J Pathol,1998, 153 (5):1333-9.
  • 2Ahmad SA, Liu W, Jung YD, et al. The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer. Cancer Res, 2001,61 (4): 1 255-9.
  • 3Lereijido M, Contreras RG, Shoshani L. Cell adhension,polarity, and epithelia in the dawn of metazoans. Physiol Rev, 2004, 84 (4): 1 229-62.
  • 4Lee TB, Min YD, Lim SC, et al. Fas (Apo-1/CD95) and Fas ligand interation between gastric cancer cells and immune cells. J Gastroenterol Hepatol, 2002, 17 ( 1 ): 32-38.
  • 5Takahama Y, Yamada Y, Emoto K, et al. The prognostic significance of overexpression of the decoy receptor for Fas ligand (Dc R3) in patients with gastric carcinomas. Gastric Cancer, 2002, 5 (2): 61-68.
  • 6Leithauser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of Apo-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest,1993, 69 (4): 415-29.
  • 7Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediatd by angiopoietins and VEGF. Science, 1999, 284 (5 422): 1 994-8.
  • 8Hata K, Nakayama K, Fujiwaki R, et al. Expression of the angopoietin-1, angopoietin-2, Tie-2, and vascular endothelial growth factor gene in epithelial ovarian cancer.Gynecol Oncol, 2004, 93 ( 1 ): 215-22.
  • 9O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma. Cell, 1994, 79(2): 315-28.
  • 10Peter CM, Chitra S, Pamela FJ, et al. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science, 1997, 277 (5 322): 55-60.

二级参考文献4

  • 1金顺钱,张伟.CD44的变异性表达和肿瘤转移[J].国外医学(分子生物学分册),1994,16(2):58-62. 被引量:35
  • 2张鸿来,吴秉铨,张卫国,方伟岗.高转移人肺巨细胞癌细胞67-KD层粘连蛋白受体基因表达[J].中华肿瘤杂志,1994,16(6):403-406. 被引量:4
  • 3S. Matsui,H. Shiozaki,M. Inoue,S. Tamura,Y. Doki,T. Kadowaki,T. Iwazawa,K. Shimaya,T. Mori,A. Nagafuchi,S. Tsukita. Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer[J] 1994,Virchows Archiv(4):375~381
  • 4Yuenian E. Shi,Jeff Torri,Lynn Yieh,Mark E. Sobel,Yoshihiko Yamada,Marc E. Lippman,Robert B. Dickson,Erik W. Thompson. Expression of 67 kDa laminin receptor in human breast cancer cells: regulation by progestins[J] 1993,Clinical &amp; Experimental Metastasis(3):251~261

共引文献4

同被引文献24

  • 1汪永平,吴翠环.新的抑癌基因tslc1研究进展[J].医学分子生物学杂志,2005,2(4):314-316. 被引量:3
  • 2拉莱.苏祖克,彭玉华,周康,房新志,王莉.新疆不同民族子宫颈癌发病趋势分析[J].新疆医科大学学报,2006,29(7):569-571. 被引量:81
  • 3凌斌.子宫颈癌诊断与治疗的新进展[J].中国实用妇科与产科杂志,2007,23(1):23-25. 被引量:66
  • 4PARKIN D M, BRAY F, FERLAY J, et al. Global canc- er statistics, 2002[J]. CA Cancer J Clin, 2005,55 (2) : 74-108.
  • 5YANG B H, BRAY F I, PARKIN D M, et al. Cervical cancer as a priority for prevention in different world re- gions: an evaluation using years of life lost[J], lnt J Cancer, 2004,109(3) : 418-424.
  • 6COHEN J. High Hopes and dilemmas for a cervical cancer vaccine[J]. Science, 2005, 308: 618-621.
  • 7KIM J H, LEE J Y, LEE KT, et al. RGSI6 and FosB un- derexpressed in pancreatic cancer with lymph node metas- tasis promote tumor progression [ J]. Tumor Biol, 2010, 31 (5) :541-548.
  • 8AL-MAYOUF S M. Loss-of-function variant in DNASEI L3 causes a familial form of systemic lupus erythematosus [J]. Nat Genet, 2011, 43(12) :1186-1188.
  • 9FERENCZY A, FRANCO E. persistent human papilloma virus infection and cervical neoplasia [ J ]. Lancet Oncol, 2002, 3 ( 1 ) : 11-16.
  • 10KRIEGER M, HERZ J. Structures and functions of multil- igand lipoprotein receptors: macrophage scavenger recep- tors and LDL receptor-related protein (LRP) [ J ]. Annu Rev Biochem, 1994, 63: 601-637.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部